NCT05721222
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05721222
Title Trial of PRO1160 (GEN1160) in Relapsed or Refractory Non-Hodgkin Lymphoma (NHL) (PRO1160-001)
Acronym PRO1160-001
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors ProfoundBio US Co.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
City of Hope Comprehensive Cancer Center - Duarte Duarte California 91010 United States Details
The City of Hope Orange County Lennar Foundation Cancer Center Irvine California 92618 United States Details
University of Michigan Ann Arbor Michigan 48109 United States Details
Karmanos Cancer Institute Detroit Michigan 48201 United States Details
Washington University School of Medicine in St. Louis St Louis Missouri 63110 United States Details
NYU Langone Health New York New York 10016 United States Details
Montefiore Medical Center - Montefiore Hospital The Bronx New York 10467 United States Details
Levine Cancer Center Charlotte North Carolina 28204 United States Details
Cleveland Clinic - Euclid Hospital Cleveland Ohio 44195 United States Details
Providence Portland Medical Center Portland Oregon 97213 United States Details
Oregon Health & Science University Portland Oregon 97239 United States Details
Sarah Cannon Research Institute - Nashville Nashville Tennessee 37203 United States Details
MD Anderson Cancer Center Houston Texas 77030 United States Details
START Mountain Cancer Center West Valley City Utah 84119 United States Details
Cancer Hospital of Chinese Academy of Medical Sciences Beijing Beijing Municipality China Details
Fudan University Shanghai Cancer Center Shanghai Shanghai Municipality China Details
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine Shanghai Shanghai Municipality China Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field